Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep:114:105117.
doi: 10.1016/j.bioorg.2021.105117. Epub 2021 Jun 23.

New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2

Affiliations

New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2

Israa A Seliem et al. Bioorg Chem. 2021 Sep.

Abstract

At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) and 6-fluoro-4-(2-(1-(4-methoxyphenyl)-1H-1,2,3-triazol-4-yl)ethoxy)-2-(trifluoromethyl)quinoline (12c) show high potency against SARS-CoV-2. The selectivity index (SI) of compounds 10g and 12c also indicates the significant efficacy compared to the reference drugs.

Keywords: Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Examples of repurposing drugs for COVID-19.
Fig. 2
Fig. 2
Designing of quinoline-triazole conjugates.
Scheme 1
Scheme 1
Synthesis of alkynes 5, 6, and 8.
Scheme 2
Scheme 2
Triazole-quinoline conjugates 10a-l, 11a-c, 12a-e.
Fig. 3
Fig. 3
Dose-response curves for the tested compounds against SARS-CoV-2.

References

    1. Lu H., Stratton C.W., Tang Y.-W. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J. Med. Virol. 2020;92(4):401–402. - PMC - PubMed
    1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S.M., Lau E.H.Y., Wong J.Y., Xing X., Xiang N., Wu Y., Li C., Chen Q.i., Li D., Liu T., Zhao J., Liu M., Tu W., Chen C., Jin L., Yang R., Wang Q.i., Zhou S., Wang R., Liu H., Luo Y., Liu Y., Shao G.e., Li H., Tao Z., Yang Y., Deng Z., Liu B., Ma Z., Zhang Y., Shi G., Lam T.T.Y., Wu J.T., Gao G.F., Cowling B.J., Yang B.o., Leung G.M., Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus-Infected pneumonia. N. Engl. J. Med. 2020;382(13):1199–1207. - PMC - PubMed
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L.i. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. - PMC - PubMed
    1. World Health Organization, Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica....
    1. Singh T.U., Parida S., Lingaraju M.C., Kesavan M., Kumar D., Singh R.K. Drug repurposing approach to fight COVID-19. Pharmacol Rep. 2020;72(6):1479–1508. - PMC - PubMed

Publication types